EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Redirecting AAV vectors to extrahepatic tissues

Aravind Asokan, Shen Shen

Molecular Therapy · 2023-12 · 31 (12) · 3371-3375

DOI: 10.1016/j.ymthe.2023.10.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Therapy, 2023-12. Verfasst von Aravind Asokan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Duke University School of Medicine, Durham, NC, USA; Department of Molecular Genetics & Microbiology, Duke University School o…. Hauptthemen laut MEDLINE: Dependovirus, Gene Transfer Techniques. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recombinant adeno-associated viral (AAV) vectors are the current benchmark for systemic delivery of gene therapies to multiple organs in vivo. Despite clinical successes, safe and effective gene delivery to extrahepatic tissues has proven challenging due to dose limiting toxicity arising from high liver uptake of AAV vectors. Deeper understanding of AAV structure, receptor biology, and pharmacology has enabled the design and engineering of liver-de-targeted capsids ushering in several new vector candidates. This next generation of AAVs offers significant promise for extrahepatic gene delivery to cardiovascular, musculoskeletal, and neurological tissues with improved safety profiles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusGene Transfer TechniquesGenetic TherapyCapsidLiverGenetic Vectors

Stichwörter der Autor:innen

adeno-associated virusadverse eventsbiodistributioncapsidextrahepaticgene deliverygene transferliver-de-targetingsafetytoxicitytropismvector engineering

Autor:innen und Institutionen

  • Department of Surgery, Duke University School of Medicine, Durham, NC, USA; Department of Molecular Genetics & Microbiology, Duke University School of Medicine, Durham, NC, USA; Department of Biomedical Engineering, Duk…
  • Vertex Pharmaceuticals, 50 Northern Avenue, Boston, MA, USA. Electronic address: shen_shen@vrtx.com.

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NIAMS NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • University of North Carolina Wilmington
  • National Institutes of Health
  • National Heart Lung and Blood Institute

Zitieren

APA

Asokan, A., & Shen, S. (2023). Redirecting AAV vectors to extrahepatic tissues. Molecular Therapy, 31(12), 3371-3375. https://doi.org/10.1016/j.ymthe.2023.10.005

Vancouver

Asokan A, Shen S. Redirecting AAV vectors to extrahepatic tissues. Molecular Therapy. 2023;31(12):3371-3375. doi:10.1016/j.ymthe.2023.10.005

BibTeX
@article{Asokan2023,
  author = {Asokan, Aravind and Shen, Shen},
  title = {Redirecting AAV vectors to extrahepatic tissues},
  journal = {Molecular Therapy},
  year = {2023},
  volume = {31},
  number = {12},
  pages = {3371--3375},
  doi = {10.1016/j.ymthe.2023.10.005}
}
Kostenlos starten →